Nephrotic syndrome in the setting of LECT2 amyloidosis: Take a look at the podocyte
Amyloid light-chain (AL) amyloidosis represents the most common type of amyloid affecting the kidneys. As AL amyloidosis is frequently clinically manifested as nephrotic syndrome, this glomerular syndrome has been improperly linked to all other types of kidney amyloidosis. In this report, we highlig...
Gespeichert in:
Veröffentlicht in: | Clinical nephrology 2020-11, Vol.94 (5), p.266-270 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 270 |
---|---|
container_issue | 5 |
container_start_page | 266 |
container_title | Clinical nephrology |
container_volume | 94 |
creator | Valdés-Lagunes, David A Méndez-Pérez, R Angélica de la Cruz, Mercedes Andrea Uribe-Uribe, Norma O Mejía-Vilet, Juan M |
description | Amyloid light-chain (AL) amyloidosis represents the most common type of amyloid affecting the kidneys. As AL amyloidosis is frequently clinically manifested as nephrotic syndrome, this glomerular syndrome has been improperly linked to all other types of kidney amyloidosis. In this report, we highlight the importance of amyloid typing, as the deposition of several amyloidotic proteins in the kidneys is not associated with heavy proteinuria. We present two cases of patients who presented with sudden-onset nephrotic syndrome and kidney biopsies showing interstitial, vascular, and/or mesangial LECT2 amyloidosis. Further examination by electron microscopy demonstrated diffuse foot process effacement consistent with minimal change disease and no amyloid deposition in the glomerular basement membrane. Both patients had complete remission after glucocorticoid treatment. We conclude that the presence of nephrotic syndrome in a patient with LECT2 amyloidosis must alert for a potential concurrent podocytopathy. |
doi_str_mv | 10.5414/CN110170 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2439631385</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2610518622</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-d7c3d03f6dadca6786e47f651e553c73ad269a66dec4b9da83bf3efcc6d10c0e3</originalsourceid><addsrcrecordid>eNpdkL1OwzAURj2AaClIPAGyxMISsHMTx2VDUfmRqjJQ5si1b2jaJA62M-TtKdCCxHSXc48-HUIuOLtJE57c5gvOGc_YERkzYDxiCbAROfV-w1jMJMgTMoJYZownckxeF9itnQ2Vpn5ojbMN0qqlYY3UYwhV-05tSeezfBlT1Qy1rYz1lb-jS7VFqmht7Zaq8P3QWWP1EPCMHJeq9ni-vxPy9jBb5k_R_OXxOb-fRxo4D5HJNBgGpTDKaCUyKTDJSpFyTFPQGSgTi6kSwqBOVlOjJKxKwFJrYTjTDGFCrn-8nbMfPfpQNJXXWNeqRdv7Ik5gKoCDTHfo1T90Y3vX7tYVseAs5VLE8Z9QO-u9w7LoXNUoNxScFV9xi0PcHXq5F_arBs0veCgLn6WLdPY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2610518622</pqid></control><display><type>article</type><title>Nephrotic syndrome in the setting of LECT2 amyloidosis: Take a look at the podocyte</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Valdés-Lagunes, David A ; Méndez-Pérez, R Angélica ; de la Cruz, Mercedes Andrea ; Uribe-Uribe, Norma O ; Mejía-Vilet, Juan M</creator><creatorcontrib>Valdés-Lagunes, David A ; Méndez-Pérez, R Angélica ; de la Cruz, Mercedes Andrea ; Uribe-Uribe, Norma O ; Mejía-Vilet, Juan M</creatorcontrib><description>Amyloid light-chain (AL) amyloidosis represents the most common type of amyloid affecting the kidneys. As AL amyloidosis is frequently clinically manifested as nephrotic syndrome, this glomerular syndrome has been improperly linked to all other types of kidney amyloidosis. In this report, we highlight the importance of amyloid typing, as the deposition of several amyloidotic proteins in the kidneys is not associated with heavy proteinuria. We present two cases of patients who presented with sudden-onset nephrotic syndrome and kidney biopsies showing interstitial, vascular, and/or mesangial LECT2 amyloidosis. Further examination by electron microscopy demonstrated diffuse foot process effacement consistent with minimal change disease and no amyloid deposition in the glomerular basement membrane. Both patients had complete remission after glucocorticoid treatment. We conclude that the presence of nephrotic syndrome in a patient with LECT2 amyloidosis must alert for a potential concurrent podocytopathy.</description><identifier>ISSN: 0301-0430</identifier><identifier>DOI: 10.5414/CN110170</identifier><identifier>PMID: 32870148</identifier><language>eng</language><publisher>Germany: Dustri - Verlag Dr. Karl Feistle GmbH & Co. KG</publisher><subject>Aged ; Amyloidosis ; Amyloidosis - complications ; Antibodies ; Biopsy ; Cholesterol ; Creatinine ; Edema ; Female ; Humans ; Intercellular Signaling Peptides and Proteins - metabolism ; Kidney - pathology ; Kidney - ultrastructure ; Kidney diseases ; Kidneys ; Male ; Metabolism ; Microscopy ; Nephrology ; Nephrotic Syndrome - etiology ; Nephrotic Syndrome - pathology ; Patients ; Podocytes - pathology ; Proteins ; Remission (Medicine)</subject><ispartof>Clinical nephrology, 2020-11, Vol.94 (5), p.266-270</ispartof><rights>Copyright Dustri - Verlag Dr. Karl Feistle GmbH & Co. KG Nov 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c311t-d7c3d03f6dadca6786e47f651e553c73ad269a66dec4b9da83bf3efcc6d10c0e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32870148$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Valdés-Lagunes, David A</creatorcontrib><creatorcontrib>Méndez-Pérez, R Angélica</creatorcontrib><creatorcontrib>de la Cruz, Mercedes Andrea</creatorcontrib><creatorcontrib>Uribe-Uribe, Norma O</creatorcontrib><creatorcontrib>Mejía-Vilet, Juan M</creatorcontrib><title>Nephrotic syndrome in the setting of LECT2 amyloidosis: Take a look at the podocyte</title><title>Clinical nephrology</title><addtitle>Clin Nephrol</addtitle><description>Amyloid light-chain (AL) amyloidosis represents the most common type of amyloid affecting the kidneys. As AL amyloidosis is frequently clinically manifested as nephrotic syndrome, this glomerular syndrome has been improperly linked to all other types of kidney amyloidosis. In this report, we highlight the importance of amyloid typing, as the deposition of several amyloidotic proteins in the kidneys is not associated with heavy proteinuria. We present two cases of patients who presented with sudden-onset nephrotic syndrome and kidney biopsies showing interstitial, vascular, and/or mesangial LECT2 amyloidosis. Further examination by electron microscopy demonstrated diffuse foot process effacement consistent with minimal change disease and no amyloid deposition in the glomerular basement membrane. Both patients had complete remission after glucocorticoid treatment. We conclude that the presence of nephrotic syndrome in a patient with LECT2 amyloidosis must alert for a potential concurrent podocytopathy.</description><subject>Aged</subject><subject>Amyloidosis</subject><subject>Amyloidosis - complications</subject><subject>Antibodies</subject><subject>Biopsy</subject><subject>Cholesterol</subject><subject>Creatinine</subject><subject>Edema</subject><subject>Female</subject><subject>Humans</subject><subject>Intercellular Signaling Peptides and Proteins - metabolism</subject><subject>Kidney - pathology</subject><subject>Kidney - ultrastructure</subject><subject>Kidney diseases</subject><subject>Kidneys</subject><subject>Male</subject><subject>Metabolism</subject><subject>Microscopy</subject><subject>Nephrology</subject><subject>Nephrotic Syndrome - etiology</subject><subject>Nephrotic Syndrome - pathology</subject><subject>Patients</subject><subject>Podocytes - pathology</subject><subject>Proteins</subject><subject>Remission (Medicine)</subject><issn>0301-0430</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkL1OwzAURj2AaClIPAGyxMISsHMTx2VDUfmRqjJQ5si1b2jaJA62M-TtKdCCxHSXc48-HUIuOLtJE57c5gvOGc_YERkzYDxiCbAROfV-w1jMJMgTMoJYZownckxeF9itnQ2Vpn5ojbMN0qqlYY3UYwhV-05tSeezfBlT1Qy1rYz1lb-jS7VFqmht7Zaq8P3QWWP1EPCMHJeq9ni-vxPy9jBb5k_R_OXxOb-fRxo4D5HJNBgGpTDKaCUyKTDJSpFyTFPQGSgTi6kSwqBOVlOjJKxKwFJrYTjTDGFCrn-8nbMfPfpQNJXXWNeqRdv7Ik5gKoCDTHfo1T90Y3vX7tYVseAs5VLE8Z9QO-u9w7LoXNUoNxScFV9xi0PcHXq5F_arBs0veCgLn6WLdPY</recordid><startdate>202011</startdate><enddate>202011</enddate><creator>Valdés-Lagunes, David A</creator><creator>Méndez-Pérez, R Angélica</creator><creator>de la Cruz, Mercedes Andrea</creator><creator>Uribe-Uribe, Norma O</creator><creator>Mejía-Vilet, Juan M</creator><general>Dustri - Verlag Dr. Karl Feistle GmbH & Co. KG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>202011</creationdate><title>Nephrotic syndrome in the setting of LECT2 amyloidosis: Take a look at the podocyte</title><author>Valdés-Lagunes, David A ; Méndez-Pérez, R Angélica ; de la Cruz, Mercedes Andrea ; Uribe-Uribe, Norma O ; Mejía-Vilet, Juan M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-d7c3d03f6dadca6786e47f651e553c73ad269a66dec4b9da83bf3efcc6d10c0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>Amyloidosis</topic><topic>Amyloidosis - complications</topic><topic>Antibodies</topic><topic>Biopsy</topic><topic>Cholesterol</topic><topic>Creatinine</topic><topic>Edema</topic><topic>Female</topic><topic>Humans</topic><topic>Intercellular Signaling Peptides and Proteins - metabolism</topic><topic>Kidney - pathology</topic><topic>Kidney - ultrastructure</topic><topic>Kidney diseases</topic><topic>Kidneys</topic><topic>Male</topic><topic>Metabolism</topic><topic>Microscopy</topic><topic>Nephrology</topic><topic>Nephrotic Syndrome - etiology</topic><topic>Nephrotic Syndrome - pathology</topic><topic>Patients</topic><topic>Podocytes - pathology</topic><topic>Proteins</topic><topic>Remission (Medicine)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Valdés-Lagunes, David A</creatorcontrib><creatorcontrib>Méndez-Pérez, R Angélica</creatorcontrib><creatorcontrib>de la Cruz, Mercedes Andrea</creatorcontrib><creatorcontrib>Uribe-Uribe, Norma O</creatorcontrib><creatorcontrib>Mejía-Vilet, Juan M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Valdés-Lagunes, David A</au><au>Méndez-Pérez, R Angélica</au><au>de la Cruz, Mercedes Andrea</au><au>Uribe-Uribe, Norma O</au><au>Mejía-Vilet, Juan M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nephrotic syndrome in the setting of LECT2 amyloidosis: Take a look at the podocyte</atitle><jtitle>Clinical nephrology</jtitle><addtitle>Clin Nephrol</addtitle><date>2020-11</date><risdate>2020</risdate><volume>94</volume><issue>5</issue><spage>266</spage><epage>270</epage><pages>266-270</pages><issn>0301-0430</issn><abstract>Amyloid light-chain (AL) amyloidosis represents the most common type of amyloid affecting the kidneys. As AL amyloidosis is frequently clinically manifested as nephrotic syndrome, this glomerular syndrome has been improperly linked to all other types of kidney amyloidosis. In this report, we highlight the importance of amyloid typing, as the deposition of several amyloidotic proteins in the kidneys is not associated with heavy proteinuria. We present two cases of patients who presented with sudden-onset nephrotic syndrome and kidney biopsies showing interstitial, vascular, and/or mesangial LECT2 amyloidosis. Further examination by electron microscopy demonstrated diffuse foot process effacement consistent with minimal change disease and no amyloid deposition in the glomerular basement membrane. Both patients had complete remission after glucocorticoid treatment. We conclude that the presence of nephrotic syndrome in a patient with LECT2 amyloidosis must alert for a potential concurrent podocytopathy.</abstract><cop>Germany</cop><pub>Dustri - Verlag Dr. Karl Feistle GmbH & Co. KG</pub><pmid>32870148</pmid><doi>10.5414/CN110170</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0301-0430 |
ispartof | Clinical nephrology, 2020-11, Vol.94 (5), p.266-270 |
issn | 0301-0430 |
language | eng |
recordid | cdi_proquest_miscellaneous_2439631385 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Aged Amyloidosis Amyloidosis - complications Antibodies Biopsy Cholesterol Creatinine Edema Female Humans Intercellular Signaling Peptides and Proteins - metabolism Kidney - pathology Kidney - ultrastructure Kidney diseases Kidneys Male Metabolism Microscopy Nephrology Nephrotic Syndrome - etiology Nephrotic Syndrome - pathology Patients Podocytes - pathology Proteins Remission (Medicine) |
title | Nephrotic syndrome in the setting of LECT2 amyloidosis: Take a look at the podocyte |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T02%3A28%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nephrotic%20syndrome%20in%20the%20setting%20of%20LECT2%20amyloidosis:%20Take%20a%20look%20at%20the%20podocyte&rft.jtitle=Clinical%20nephrology&rft.au=Vald%C3%A9s-Lagunes,%20David%20A&rft.date=2020-11&rft.volume=94&rft.issue=5&rft.spage=266&rft.epage=270&rft.pages=266-270&rft.issn=0301-0430&rft_id=info:doi/10.5414/CN110170&rft_dat=%3Cproquest_cross%3E2610518622%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2610518622&rft_id=info:pmid/32870148&rfr_iscdi=true |